Supraventricular Tachycardia (SVT)

Supraventricular Tachycardia (SVT)

News & Stories

Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
Diagram of a precision medicine pipeline linking patients with small animal models through three stages: high-throughput behavioral screening of sleep and activity, identification of brain, heart and molecular biomarkers, and high-throughput testing of dietary, drug and time-based treatments.
Research News

Pioneering a precision medicine pipeline for bipolar disorder

Angel Lopez, Ph.D., explores a precision medicine pipeline using genetic mouse models to identify biomarkers and potential treatments for bipolar disorder.
Maize block M with Michigan Medicine, University of Michigan under
Department News

Family Medicine clinician-researchers publish two papers in leading primary health journal

Family Medicine Doctors Lauren Oshman and Katherine Hughey are among two teams of authors who have published papers in the September/October 2026 issue of Annals of Family Medicine.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.
Dr. Madison
Department News

Faculty Spotlight: Jacqueline Madison Advances Care for Patients with Autoimmune Disease

For Jacqueline Madison, MD, a career in rheumatology began with an early lesson in the power of long-term, relationship-centered care.
scratching arm pink sweater in living room teal couch
Health Lab

A metabolic “switch” that could help reset scar-producing cells in scleroderma

Researchers at University of Michigan Health and collaborating institutions have identified a metabolic enzyme that may offer a fundamentally new way to attack one of the most difficult-to-treat features of systemic sclerosis, or scleroderma: progressive and potentially life threatening tissue scarring.